Atlas Trials

A Study to Evaluate the Effect of KarXT on Urological Safety

Clinical trial NCT07221877 · RECRUITING

Trial details

NCT number
NCT07221877
Sponsor
Bristol-Myers Squibb
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Schizophrenia
Start date
2026-01-20
Primary completion
2027-12-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.